Overview

Autologous Stem Cell Transplant (ASCT) With Intravenous Busulfan and Melphalan as Conditioning Regimen

Status:
Unknown status
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
Analyze the results of ASCT using intravenous Busulfan and Melphalan as conditioning regimen for patients with Multiple Myeloma.
Phase:
Phase 2
Details
Lead Sponsor:
Fundacion Para La Investigacion Hospital La Fe
Treatments:
Busulfan
Melphalan